Ten NIHers Elected as 2022 AAAS Fellows
Congratulations to the 10 NIHers who were elected as new members of the American Association for the Advancement of Science (AAAS). In October 2022, the AAAS Council elected 505 members as Fellows of AAAS. This honor recognizes fellows for their achievements across disciplines from research, teaching, and technology, to administration in academia, industry and government, to excellence in communicating and interpreting science to the public.
Karen Faith Berman, M.D. (National Institute of Mental Health) was recognized for distinguished translational studies using multimodal neuroimaging to bridge the gap between neurogenetic, molecular, cellular, and system-level mechanisms of brain dysfunction and the cognitive and behavioral manifestations of neuropsychiatric disorders.
Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.S. (National Institute of Environmental Health Sciences) was recognized for distinguished leadership in the field of toxicology, especially pharmacokinetic behavior of environmental chemicals, mechanisms of action of toxicants including endocrine disruption, and linking of real-world exposures to health effects.
Cynthia E. Dunbar, M.D. (National Heart, Lung, and Blood Institute) was recognized for research on how hematopoiesis is controlled in vivo and the development and use of a nonhuman primate model for optimization of gene therapy, stem-cell transplantation, and other clinical interventions.
Eric A. Engels, M.D., M.P.H. (National Cancer Institute) was recognized for distinguished contributions in identifying and quantifying the risk of cancer in immunosuppression, including in persons living with HIV and recipients of organ transplants.
Elodie Ghedin, Ph.D. (National Institute of Allergy and Infectious Diseases) was recognized for distinguished contributions in infectious diseases, particularly in applying systems biology approaches to understanding host-pathogen interactions.
Paul P. Liu, M.D., Ph.D. (National Human Genome Research Institute) was recognized for distinguished contributions to the field of hematology and leukemia research, particularly the seminal discovery of the link of CBFB-MYH11 to leukemia and regulation of hematopoiesis by RUNX1 and CBFB.
Christopher J. McBain, Ph.D. (Eunice Kennedy Shriver National Institute of Child Health and Human Development) was recognized for contributing insight into mechanisms of cortical and hippocampal synaptic transmission and how voltage and ligand-gated channels expressed in inhibitory neurons regulate circuit excitability, with a focus on development.
Lee Scott Weinstein, M.D. (National Institute of Diabetes and Digestive and Kidney Diseases) was recognized for distinguished contributions to the fields of endocrinology and metabolism, particularly defining genetic and epigenetic defects associated with endocrine disorders and the role of G-protein signaling in metabolic regulation.
Carmen J. Williams, M.D., Ph.D. (National Institute of Environmental Health Sciences) was recognized for distinguished contributions to reproductive and developmental biology, particularly for elucidation of mechanisms underlying fertilization and early mammalian development.
Howard A. Young, Ph.D. (National Cancer Institute) was recognized for distinguished contributions to the field of immunology and the understanding of the role of interferons in initiating and promoting sex-biased autoimmune diseases.
This page was last updated on Thursday, March 16, 2023